Cargando…

Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study

BACKGROUND: Although intracranial metastatic disease (IMD) is a frequent complication of cancer, most cancer registries do not capture these cases. Consequently, a data-gap exists, which thwarts system-level quality improvement efforts. The purpose of this investigation was to determine the real-wor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habbous, Steven, Forster, Katharina, Darling, Gail, Jerzak, Katarzyna, Holloway, Claire M B, Sahgal, Arjun, Das, Sunit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872008/ https://www.ncbi.nlm.nih.gov/pubmed/33585818 http://dx.doi.org/10.1093/noajnl/vdaa178

Ejemplares similares

Variation in Diagnosis, Treatment, and Outcome of Esophageal Cancer in a Regionalized Care System in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2021)

Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease: A Systematic Review and Meta-analysis
por: Li, Alyssa Y., et al.
Publicado: (2023)

Analysis of Rates of Brain Metastases and Association With Breast Cancer Subtypes in Ontario, Canada
por: Wang, Xin Ye, et al.
Publicado: (2022)

PD-L1 expression in breast cancer brain metastases
por: Chehade, Rania, et al.
Publicado: (2022)

HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysis
por: Erickson, Anders W, et al.
Publicado: (2020)

The effect of diagnostic assessment programs on the diagnosis and treatment of patients with lung cancer in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2021)

CHOREOGRAPHED EXPANSION OF SERVICES RESULTS IN DECREASED PATIENT BURDEN WITHOUT COMPROMISE OF OUTCOMES: AN ASSESSMENT OF THE ONTARIO EXPERIENCE
por: Rzadki, Kathryn, et al.
Publicado: (2023)

Dual- versus single-agent HER2 inhibition and incidence of intracranial metastatic disease: a systematic review and meta-analysis
por: Erickson, Anders Wilder, et al.
Publicado: (2021)

THER-01. Targeted therapy and intracranial metastatic disease: a population-based retrospective cohort study
por: Erickson, Anders, et al.
Publicado: (2021)

TREATMENT, HEALTHCARE UTILIZATION AND OUTCOMES IN PATIENTS WITH GLIOBLASTOMA IN ONTARIO: A 10-YEAR COHORT STUDY
por: Rzadki, Kathryn, et al.
Publicado: (2023)

Intracranial Metastatic Disease: Present Challenges, Future Opportunities
por: Li, Alyssa Y., et al.
Publicado: (2022)

Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
por: Soliman, Hany, et al.
Publicado: (2016)

Editorial: Contemporary Management of Intracranial Metastatic Disease
por: Das, Sunit, et al.
Publicado: (2019)

Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study
por: Habbous, Steven, et al.
Publicado: (2022)

Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
por: Das, Sunit, et al.
Publicado: (2020)

The Early Burden of Disability in Individuals With Mood and Other Common Mental Disorders in Ontario, Canada
por: Frey, Benicio N., et al.
Publicado: (2020)

Disparities in Physician Compensation by Gender in Ontario, Canada
por: Steffler, Mitch, et al.
Publicado: (2021)

Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic
por: Walker, Meghan J., et al.
Publicado: (2022)

Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review
por: Hafazalla, Karim, et al.
Publicado: (2018)

The effect of the COVID-19 pandemic on hospital admissions and outpatient visits in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2023)

Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2022)

Hypofractionated Stereotactic Radiotherapy in Five Daily Fractions for Post-Operative Surgical Cavities in Brain Metastases Patients with and without Prior Whole Brain Radiation
por: Al-Omair, Ameen, et al.
Publicado: (2013)

Salpingectomy and the Risk of Ovarian Cancer in Ontario
por: Giannakeas, Vasily, et al.
Publicado: (2023)

Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
por: Kaka, Nagham, et al.
Publicado: (2019)

Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care System
por: Martens, Kylee L., et al.
Publicado: (2023)

Association of Innovations in Radiotherapy and Systemic Treatments With Clinical Outcomes in Patients With Melanoma Brain Metastasis From 2007 to 2016
por: Brastianos, Harry C., et al.
Publicado: (2020)

Advanced Magnetic Resonance Imaging Techniques in Management of Brain Metastases
por: Mehrabian, Hatef, et al.
Publicado: (2019)

Changes in hospitalizations and emergency department respiratory viral diagnosis trends before and during the COVID-19 pandemic in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2023)

Assessment of Effectiveness and Safety of Osimertinib for Patients With Intracranial Metastatic Disease: A Systematic Review and Meta-analysis
por: Erickson, Anders W., et al.
Publicado: (2020)

Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors
por: Shao, Changxia, et al.
Publicado: (2020)

Restructuring Skin Cancer Care in Ontario: A Provincial Plan
por: Milkovich, John, et al.
Publicado: (2021)

Prevalence, Cost, and Variation in Cost of Pediatric Hospitalizations in Ontario, Canada
por: Gill, Peter J., et al.
Publicado: (2022)

Characterization of Hip Fractures Among Adults With Schizophrenia in Ontario, Canada
por: Ansari, Hina, et al.
Publicado: (2023)

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma
por: Habbous, Steven, et al.
Publicado: (2020)

Quality of Antenatal Care for Women Who Experience Imprisonment in Ontario, Canada
por: Carter Ramirez, Alison, et al.
Publicado: (2020)

Association of Preexisting Disability With Severe Maternal Morbidity or Mortality in Ontario, Canada
por: Brown, Hilary K., et al.
Publicado: (2021)

Pediatric Patients Hospitalized With Eating Disorders in Ontario, Canada, Over Time
por: Smith, Sarah, et al.
Publicado: (2023)

An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid Tumors
por: Ravi, Dashnamoorthy, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Karnofsky Performance Status (KPS) ≤60 Is Strongly Associated With Shorter Brain-Specific Progression-Free Survival Among Patients With Metastatic Breast Cancer With Brain Metastases
por: Freeman, Mark, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l4en1cjb7ong4qinaommnotcsl